The Ever-Changing Hard Surface Disinfectant Landscape in COVID-19 Times

Posted April 16, 2020

By: Teri Dickinson, Regulatory Affairs Group Manager, email

These days, the world of hard surface disinfectants and pathway to registration changes almost weekly. With the health and safety of Canadians being at the forefront, the quick access to disinfectant products has been a top priority.

Health Canada has implemented interim measures to expedite access to disinfectants to address product shortages. Health Canada has published a list of hard-surface disinfectants that are likely to be effective for use against coronavirus (COVID-19).

Would you like your product to be on the list? Do you want to make indirect efficacy claims for SARS-CoV-2, the virus that causes COVID-19? Your product will need to be reviewed and approved with one or more of the following:

the product is labelled as a broad-spectrum virucide, that is supported by an efficacy claim against any of:
- Adenovirus type 5
- Bovine Parovirus
- Canine Parvovirus
- Poliovirus type 1;
the product carries a specific claim against non-enveloped viruses of the picornaviridae, caliciviridae, astroviridae, reoviridae, or papillomaviridae families; or,
the product carries a specific claim against a specific coronavirus, such as:
- MERS-CoV
- SARS-CoV
- human coronavirus strain 229E.

If you don’t see your product on the list and need to know how to get it listed, or if you need help to submit an expedited review application for your disinfectant that can demonstrate efficacy against the COVID-19 virus, Dell Tech can help with this and provide up-to-date information to keep you ahead in these changing times.

Contact:
Dell Tech Laboratories
info@delltech.com
519-858-5021